Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 592

1.

USP chapter 797: establishing a practice standard for compounding sterile preparations in pharmacy.

Kastango ES, Bradshaw BD.

Am J Health Syst Pharm. 2004 Sep 15;61(18):1928-38. No abstract available.

PMID:
15487884
2.

USP publishes enforceable chapter on sterile compounding.

Thompson CA.

Am J Health Syst Pharm. 2003 Sep 15;60(18):1814, 1817-8, 1822. No abstract available.

PMID:
14521028
3.

USP general chapter <797> pharmaceutical compounding-sterile preparations.

Hung JC.

J Nucl Med. 2004 Jun;45(6):20N, 28N. No abstract available.

4.

Compounding USP <797>: inspection, regulation, and oversight of sterile compounding pharmacies.

Kastango ES.

JPEN J Parenter Enteral Nutr. 2012 Mar;36(2 Suppl):38S-39S. doi: 10.1177/0148607111434779. Epub 2012 Jan 24.

PMID:
22275322
6.

Revisions continue on USP sterile-compounding chapter.

Thompson CA.

Am J Health Syst Pharm. 2005 Sep 15;62(18):1856, 1858, 1861-2. No abstract available.

PMID:
16141100
7.

Joint Commission expectations related to USP-NF Chapter 797 on compounding sterile preparations.

[No authors listed]

Jt Comm Perspect. 2006 Apr;26(4):5. No abstract available.

PMID:
16786622
8.
9.

The potential impact of USP 797 and what the JCAAI is doing about it.

Nathan R.

Allergy Asthma Proc. 2007 Mar-Apr;28(2):236-7. No abstract available.

PMID:
17479611
10.

Blueprint for implementing USP chapter 797 for compounding sterile preparations.

Kastango ES; American Society of Health-System Pharmacists (ASHP).

Am J Health Syst Pharm. 2005 Jun 15;62(12):1271-88.

PMID:
15947127
11.

Impact of United States Pharmacopeia chapter 797: results of a national survey.

Candy TA, Schneider PJ, Pedersen CA.

Am J Health Syst Pharm. 2006 Jul 15;63(14):1336-43.

PMID:
16809754
12.

Compounding parenteral nutrition: reducing the risks.

Curtis C, Sacks GS.

Nutr Clin Pract. 2009 Aug-Sep;24(4):441-6. doi: 10.1177/0884533609339070. Review.

PMID:
19605798
13.

Does your pharmacy have a compounding isolator?

LaBella CJ.

Am J Health Syst Pharm. 2007 Apr 15;64(8):855-8. No abstract available.

PMID:
17420203
14.

A collaborative effort to comply with USP chapter 797 for compounding sterile preparations for investigational use.

Formea CM, Weiss WT, McCluskey SV.

Am J Health Syst Pharm. 2008 Jul 1;65(13):1266-9. doi: 10.2146/ajhp070497.

PMID:
18574018
15.

Potential for airborne contamination in turbulent- and unidirectional-airflow compounding aseptic isolators.

Peters GF, McKeon MR, Weiss WT.

Am J Health Syst Pharm. 2007 Mar 15;64(6):622-31.

PMID:
17353571
16.
18.

USP releases revision of chapter on sterile compounding: new version of USP chapter 797 emphasizes personnel.

Thompson CA.

Am J Health Syst Pharm. 2008 Jan 15;65(2):104, 111. doi: 10.2146/news080007. No abstract available.

PMID:
18192250
19.

Microbial contamination of syringes during preparation: the direct influence of environmental cleanliness and risk manipulations on end-product quality.

Stucki C, Sautter AM, Favet J, Bonnabry P.

Am J Health Syst Pharm. 2009 Nov 15;66(22):2032-6. doi: 10.2146/ajhp070681.

PMID:
19890087
20.

Effect of two work practice changes on the microbial contamination rates of pharmacy-compounded sterile preparations.

Trissel LA, Gentempo JA, Saenz LM, Woodard MY, Angeles CH.

Am J Health Syst Pharm. 2007 Apr 15;64(8):837-41.

PMID:
17420200

Supplemental Content

Support Center